|
市場調査レポート
商品コード
1219645
空の輸液バッグの世界市場規模、シェア、産業動向分析レポート:製品別(PVCと非PVC(シングルチャンバーとマルチチャンバー))、地域別展望と予測、2022年~2028年Global Empty IV Bags Market Size, Share & Industry Trends Analysis Report By Product (PVC and Non-PVC (Single Chamber and Multi Chamber)), By Regional Outlook and Forecast, 2022 - 2028 |
||||||
空の輸液バッグの世界市場規模、シェア、産業動向分析レポート:製品別(PVCと非PVC(シングルチャンバーとマルチチャンバー))、地域別展望と予測、2022年~2028年 |
出版日: 2023年01月31日
発行: KBV Research
ページ情報: 英文 181 Pages
納期: 即納可能
|
空の輸液バッグの世界市場規模は、2028年までに67億米ドルに達し、予測期間中にCAGR7.8%の市場成長率で上昇すると予測されています。
点滴バッグは、病院や入院・外来患者を対象とした医療機関など、処方箋が必要な医療環境でのみ使用されています。PVC製の空の輸液バッグは、医療機器から漏出するフタル酸エステル類によって、人の健康と環境の両方に脅威を与えるというのが、医療分野で行われた広範な研究の結論でした。また、塩ビ素材は燃焼処理されるため、有害な塩化水素(HCL)ガスが発生します。
これが酸性雨の問題にさらに拍車をかけています。医療現場が塩ビを含まない空の輸液バッグの使用に切り替えれば、世界の患者さんの健康と安全を守るために大きく前進する可能性があります。このような背景から、非塩ビ製の空輸液バッグの利用が促進され、市場の拡大が見込まれています。
COVID-19の影響分析
COVID-19によるパンデミックは、世界規模のヘルスケアセクターに様々な難題を突きつけています。様々な疾病に苦しむ患者が、医療サービス提供の制限を受けた結果、適切な医療施設を利用することが難しくなっています。一方、COVID-19に起因する入院患者の急増は、世界中のあらゆる病院で点滴治療に使用される点滴バッグの需要を増加させる結果となりました。このため、パンデミック収束後も、市場は大きく成長することが予想されます。
市場の成長要因
がんの報告件数の増加
世界保健機関(WHO)によると、がんは世界で2番目に大きな死因となっています。2018年には、推定960万人ががんで死亡し、死亡者の6人に1人ががんで死亡した原因となっています。今後、その優位性はさらに高まると予想されます。一般にがんは、胃潰瘍の増加、消化器系の正常な動作の阻害、物理的な障害などを引き起こし、非経口栄養の必要性を増加させる。
塩ビ製輸液バッグの使用禁止で伸長率アップ
塩ビは、塩化ビニルモノマー(VCM)と二塩化エチレンが主成分(EDC)です。VCMは強い発がん性を持っています。EDCの製造過程でダイオキシンが発生し、神経毒を持つ。塩ビ工場の従業員とその周辺の地域社会は、この直接的な結果として、がんやその他の病気の発生率の上昇に苦しんでいます。空輸液バッグの市場は、環境に配慮した輸液バッグへの需要が高まっていることから、成長を続けています。
市場の抑制要因
点滴治療による副作用の可能性
ビタミン剤の点滴治療には大きなリスクが伴いますが、訓練を受けた医療従事者の監督のもと、安全対策に十分配慮して実施すれば、その大半は軽減される可能性があります。ビタミンIVの注入は、時にいくつかの困難をもたらすかもしれません。認定された医療専門家が治療を提供するためにアクセスできない場合、それは病院の設定で行う必要があります。ビタミンを過剰に摂取することは有害である可能性があります。例えば、ビタミンAの過剰摂取は、頭痛やめまいから、最も困難な状況では死に至るまで、有害な結果をもたらすかもしれません。
製品の展望
空輸液バッグの市場は、製品によってPVCと非PVCに分類されます。2021年の市場全体では、非PVCセグメントが大きな収益部分を占めています。無毒な点滴容器へのニーズの高まりと、PVCの使用を禁止する厳格な法律により、PVCを含まない素材への需要が増加すると予測されます。これらのバッグは、輸送に伴う困難や薬剤包装材料と使い捨て容器との相互作用など、従来のPVC製空輸液バッグに関連するリスクの低減に貢献します。
地域別の展望
空輸液バッグ市場は地域別に、北米、欧州、アジア太平洋、LAMEAに分類されます。2021年の空輸液バッグ市場では、北米が最も高い収益シェアを占め、主要地域となっています。同地域で空の輸液バッグの受け入れが増加している要素の1つは、ヘルスケア技術へのアクセスのしやすさです。また、この採用に寄与しているもう一つの側面は、強力な流通経路の開発です。病気の発生率の高さ、支持的な診療報酬政策、確立された規制の枠組みなどの要素が、同地域における空の輸液バッグの使用増加に貢献すると予想されます。
List of Figures
The Global Empty IV Bags Market size is expected to reach $6.7 billion by 2028, rising at a market growth of 7.8% CAGR during the forecast period.
An intravenous (IV) bag that has been emptied is a sterile container that may be used for the storage and transportation of intravenous fluids or other drugs. It is often constructed of plastic or paper and has a valve that enables fluid or medicine to be infused into the bloodstream of the patient.
Empty intravenous (IV) bags are medical devices that are designed for the transfer and mixing of pharmaceuticals. They are also used for the intravenous administration of solutions via the use of a spike port. In most cases, the gadgets in question do not have a tamper-proof function. The FDA has given its approval to attachments for these devices that are designed to create a tamper-proof closure for intravenous bags.
IV bags are exclusively used in medical environments that need a prescription, such as hospitals and other medical institutions that provide inpatient and outpatient care. PVC-made empty IV bags pose a threat to both human health and the environment as a result of phthalates leaking from medical equipment, as was the conclusion of extensive studies conducted in the area of medicine. In addition, the combustion method for disposing of PVC materials leads to the generation of the harmful gas hydrogen chloride (HCL).
This adds even more to the problem of acid rain. The medical profession has the potential to make substantial headway in protecting the health and safety of the world's patient population if they switch to using empty IV bags that do not contain PVC. These kinds of elements are projected to propel the usage of non-PVC empty IV bags, which will, in turn, contribute to the expansion of the market.
COVID-19 Impact Analysis
The pandemic caused by COVID-19 has presented the healthcare sector on a global scale with a variety of difficult issues. Patients suffering from a wide range of illnesses have less access to proper medical facilities as a result of restrictions placed on medical service provision. On the other hand, the spike in hospital admission rates that has been attributed to COVID-19 has resulted in an increase in the demand for intravenous bags that are used in IV treatment across all hospital settings worldwide. As a result, even after the pandemic has been contained, it is anticipated that the market will see the growth that is both considerable and ongoing.
Market Growth Factors
An increasing number of reported instances of cancer
According to the World Health Organization (WHO), cancer is the second biggest cause of death worldwide. In 2018, an estimated 9.6 million people died from cancer, making it the cause of one out of every six fatalities. It is anticipated that the predominance will increase even more in the years to come. Cancer, in general, leads to a rise in the prevalence of stomach ulcers, interruptions in the normal operation of the gastrointestinal system, and the creation of physical obstructions; all of these factors contribute to an increased requirement for parenteral nourishment.
Prohibition of the use of iv bags made of PVC boosts the rate of growth
The vinyl chloride monomer (VCM) and ethylene dichloride that go into the production of PVC are the two main ingredients (EDC). VCM is a strong carcinogen. Dioxin is produced during the manufacturing of EDC, which is neurotoxic. The employees at the PVC factory and the communities that surround it suffer from elevated incidences of cancer and other ailments as a direct consequence of this. The market for empty IV bags has seen growth as a result of the rising demand for IV bags that are beneficial to the environment.
Market Restraining Factors
The Potential for Adverse Consequences from IV Treatment
Even while vitamin IV therapies have significant risks, the majority of those negatives may be mitigated if they are administered under the supervision of a trained medical expert who adheres to prudent safety policy. Infusions of vitamin IV might provide a few difficulties at times. If certified medical experts are not accessible to deliver the therapy, it must be done so in a hospital setting. It's possible that having excessive amounts of some vitamins in your body might be harmful. For instance, consuming an excessive amount of vitamin A might result in adverse consequences ranging from headaches and dizziness to even death in the most difficult situations.
Product Outlook
Based on product, the market for empty IV bags are classified into PVC and non-PVC. The non-PVC segment represented a significant revenue portion of the overall market in 2021. It is anticipated that there will be a rise in demand for materials that do not contain PVC because of the growing need for non-toxic IV containers and the rigorous law that prohibits the use of PVC. These bags help reduce the risks that are associated with traditional PVC empty IV bags, including the difficulties associated with transportation and the interaction between drug packaging material and disposable containers.
Regional Outlook
Based on region, the empty IV bags market is categorized into North America, Europe, Asia Pacific, and LAMEA. North America was the leading region in the market for empty IV bags in 2021, accounting for the highest revenue share. One of the elements that is contributing to the increased acceptance of empty IV bags in the area is the ease of access to healthcare technology. Another aspect contributing to this adoption is the development of strong distribution channels. It is anticipated that factors such as a high illness incidence, supportive reimbursement policies, and an established regulatory framework would all contribute to an increase in the use of empty IV bags in the area.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., B. Braun Medical Inc., ICU Medical, Inc., Becton, Dickinson and Company, Fresenius SE & Co. KGaA, Wipak Oy (Wihuri Group), Renolit SE, Technoflex, Medippex Group, and Polycine GmbH.
Market Segments covered in the Report:
By Product
By Geography
Companies Profiled
Unique Offerings from KBV Research